HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is level V neck dissection necessary in primary parotid cancer?

AbstractOBJECTIVES/HYPOTHESIS:
This study aims to evaluate the pattern of nodal metastasis to level V in parotid cancer and to examine the clinical value of level V neck dissection (LVND).
STUDY DESIGN:
Retrospective cohort study.
METHODS:
Retrospective chart review of 86 patients (47 N0 nodal metastasis [N0] neck and 39 positive nodal metastasis [N(+) ] neck) who received parotidectomy and neck dissection was performed. The prevalence of pathological nodal metastasis in level V neck was evaluated and correlated with locoregional recurrence.
RESULTS:
LVND was performed in 10.6% and 28.2% of patients with clinical NO (cN0) and cN(+) neck disease, respectively. The prevalence of pathological positive nodal metastasis was 0% (cN0) and 81.8% (cN(+) ). In patients with cN0 neck, the rate of recurrence in level V was 6%.
CONCLUSION:
In our patient cohort with predominantly high-grade parotid cancer, LVND was necessary in patients with cN(+) neck because there was a high likelihood for pathologically positive nodal metastasis. In patients with cN0 neck, the rate of recurrence in level V was low enough not to warrant a routine inclusion of LVND.
AuthorsChwee M Lim, Mark Gilbert, Jonas T Johnson, Seungwon Kim
JournalThe Laryngoscope (Laryngoscope) Vol. 125 Issue 1 Pg. 118-21 (Jan 2015) ISSN: 1531-4995 [Electronic] United States
PMID24965707 (Publication Type: Journal Article)
Copyright© 2014 The American Laryngological, Rhinological and Otological Society, Inc.
Topics
  • Aged
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis (pathology)
  • Male
  • Middle Aged
  • Neck Dissection (methods)
  • Neoplasm Recurrence, Local (mortality, pathology, prevention & control)
  • Neoplasm Staging
  • Parotid Gland (pathology, surgery)
  • Parotid Neoplasms (mortality, pathology, surgery)
  • Pennsylvania
  • Registries
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: